Recent advances in the role of Sphingosine 1-phosphate in cancer
Pyne, Nigel J. and Pyne, Susan (2020) Recent advances in the role of Sphingosine 1-phosphate in cancer. FEBS Letters, 594 (22). pp. 3583-3601. ISSN 0014-5793 (https://doi.org/10.1002/1873-3468.13933)
Preview |
Text.
Filename: Pyne_Pyne_FEBSL_2020_Recent_advances_in_the_role_of_sphingosine_1_phosphate.pdf
Final Published Version License: Download (1MB)| Preview |
Abstract
Sphingosine 1-phosphate (S1P) is a bioactive lipid that binds to a family of G protein-coupled receptors (S1P 1–5) and intracellular targets, such as HDAC1/2, that are functional in normal and pathophysiologic cell biology. There is a significant role for sphingosine 1-phosphate in cancer underpinning the so-called hallmarks, such as transformation and replicative immortality. In this review, we survey the most recent developments concerning the role of sphingosine 1-phosphate receptors, sphingosine kinase and S1P lyase in cancer and the prognostic indications of these receptors and enzymes in terms of disease-specific survival and recurrence. We also provide evidence for identification of new therapeutic approaches targeting sphingosine 1-phosphate to prevent neovascularisation, to revert aggressive and drug-resistant cancers to more amenable forms sensitive to chemotherapy, and to induce cytotoxicity in cancer cells. Finally, we briefly describe current advances in the development of isoform-specific inhibitors of sphingosine kinases for potential use in the treatment of various cancers, where these enzymes have a predominant role. This review will therefore highlight sphingosine 1-phosphate signalling as a promising translational target for precision medicine in stratified cancer patients.
ORCID iDs
Pyne, Nigel J. ORCID: https://orcid.org/0000-0002-5657-4578 and Pyne, Susan ORCID: https://orcid.org/0000-0002-6608-9584;-
-
Item type: Article ID code: 73944 Dates: DateEvent30 November 2020Published23 September 2020Published Online8 September 2020AcceptedSubjects: Medicine > Pharmacy and materia medica Department: Faculty of Science > Strathclyde Institute of Pharmacy and Biomedical Sciences Depositing user: Pure Administrator Date deposited: 22 Sep 2020 13:52 Last modified: 20 Nov 2024 09:50 Related URLs: URI: https://strathprints.strath.ac.uk/id/eprint/73944